AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 32 filers reported holding AGEX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,160 | +12.7% | 37,000 | +48.0% | 0.01% | +60.0% |
| Q2 2023 | $22,330 | +3.6% | 25,000 | -23.1% | 0.01% | -16.7% |
| Q1 2023 | $21,548 | +13.3% | 32,500 | -1.5% | 0.01% | +20.0% |
| Q4 2022 | $19,015 | +5.6% | 33,000 | +1.5% | 0.01% | 0.0% |
| Q3 2022 | $18,000 | -5.3% | 32,500 | -1.5% | 0.01% | 0.0% |
| Q2 2022 | $19,000 | -32.1% | 33,000 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $28,000 | 0.0% | 33,000 | +29.4% | 0.01% | 0.0% |
| Q4 2021 | $28,000 | +47.4% | 25,500 | +24.4% | 0.01% | +40.0% |
| Q3 2021 | $19,000 | -40.6% | 20,500 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $32,000 | -3.0% | 20,500 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $33,000 | +37.5% | 20,500 | +32.3% | 0.01% | +28.6% |
| Q4 2020 | $24,000 | +1100.0% | 15,500 | -34.0% | 0.01% | – |
| Q3 2020 | $2,000 | -88.2% | 23,500 | +34.3% | 0.00% | -100.0% |
| Q2 2020 | $17,000 | – | 17,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,997,156 | $2,038,066 | 0.18% |
| Beirne Wealth Consulting Services, LLC | 18,000 | $16,077 | 0.01% |
| Strategic Wealth Investment Group, LLC | 92,603 | $62,970 | 0.01% |
| Prescott General Partners LLC | 185,185 | $125,926 | 0.01% |
| Summit X, LLC | 37,000 | $25,160 | 0.01% |
| Sigma Planning Corp | 181,385 | $123,342 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 144,770 | $98,444 | 0.00% |
| Piscataqua Savings Bank | 1,000 | $680 | 0.00% |
| UBS Group AG | 235 | $160 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 74 | $50 | 0.00% |